Comparative study of the immune response to vaccine antigens in mice or guinea-pigs coming from different breeders;Etude comparative de la réponse immunitaire à des antigènes vaccinaux chez des souris et des cobayes provenant d'élevages différents

Sciences et Techniques de l'Animal de Laboratoire

Volumn 30, Issue 1-2, 2005, Pages 7-18

  Jourdier, Thérèse Marie ^a   Boudet, Florence ^a   Boucaud, Nelly ^a   Perrier Michon, Marie Laure ^a   Gregoire, Véronique ^a   Ramirez, Laurence ^a   Rossignol, Danièle ^a   Gautier, Valérie ^a   Rossin, Danièle ^a   Thenadey, Muriel ^a   Hessler, Catherine ^a   De Montfort, Aymeric ^a   Burdin, Nicolas ^a   Moste, Catherine ^a  

^a SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 21044439184     PISSN: 0339722X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Fiesting MF (1974) Genetic reliability of commercially-bred laboratory mice. Lab animals 8 (3), 265-270
2. Gringeri A, Santagostino E, Muça-Perja M, Le Buanec H, Bizzini B, Lachgar A, Zagury JF, Rappaport J, Burny A, Gallo R, Zagury D (1999) Tat toxoid as a component of a preventive vaccine in seronegative subjects. J Acquired Immune Defic Syndr Hum Retrovirol 20 (4), 371-375
3. Haley PJ (2003) Species differences in the structure and function of the immune system. Toxicology 188, 49-71
4. Kloting I, Nitschke C, van den Brandt J (2002) Impact of genetic profiles on experimental studies: outbred versus wild rats. Toxicology and Applied Pharmacology 169, 68-71
5. Le Buanec H, Bizzini B (2000) Procedures for preparing biologically inactive, but immunogenic VIH-1 Tat protein (Tat Toxoid) for human use. Biomed. & Pharmacother. 54, 41-44
6. Pialoux G, Excler JL, Rivière Y, Gonzales-Canali G, Feuillie V, Coulaud P, Gluckman JC, Matthews TJ, Meignier B, Kieny et al (1995) A prime-boost approach to VIH preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de recherche sur le SIDA. AIDS Res Hum Retroviruses 11, 373-381
7. Tartaglia J, Cox WI, Taylor J, Perkus M, Rivière M, Meignier B, Paoletti E (1992) Highly attenuated poxvirus vectors. AIDS Res Hum Retroviruses 8, 1445-1447
8. Tartaglia J, Excler JL, El Habib R, Limbach K, Meignier B, Plotkin S, Klein M (1998) Canarypox virus-based vaccines: prime-boost stategies to induce cell-mediated and humoral immunity against VIH. AIDS Research & Human Retroviruses 14, suppl 3 S291-298